CN Stock MarketDetailed Quotes

688192 Dizal Pharmaceutical

Watchlist
  • 47.74
  • +0.42+0.89%
Market Closed Nov 12 15:00 CST
19.84BMarket Cap-23704P/E (TTM)

Dizal Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dizal Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
134.90M
--
+236.39%
Net Income
--
-217.35M
--
+30.93%
Analyst Rating
Strong Buy

Nov 12, 2024

Dizal Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/FY -- / 947.310M --
-- 2024/FY -- / 455.652M --
-- 2023/FY 91.289M / 108.000M --
Mar 24, 2023 2022/FY 0.000 / 0.000 --
Feb 26, 2022 2021/FY 10.285M / 11.000M --
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 947.310M--
--2024/FY-- / 455.652M--
--2023/FY91.289M / 108.000M--
Mar 24, 20232022/FY0.000 / 0.000--
Feb 26, 20222021/FY10.285M / 11.000M--

Unlock Free Earnings Estimates

Dizal Pharmaceutical Earnings Reports

  • Digel Pharmaceuticals: Digel Pharmaceuticals: Report for the Third Quarter of 2024

    Oct 31 00:00

  • Digel Pharmaceuticals: Third Quarter Report 2024

    Oct 31 00:00

  • Digel Pharmaceuticals: 2024 Semi-Annual Report

    Aug 30 00:00

  • Digel Pharmaceuticals: 2024 Semi-Annual Report Summary

    Aug 30 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 12, 2024

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      20.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data